Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP) price on Thursday, July 03, fall -0.52% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $7.71.
A look at the stock’s price movement, the close in the last trading session was $7.75, moving within a range at $7.58 and $7.9. The beta value (5-Year monthly) was 3.117. Turning to its 52-week performance, $61.90 and $4.64 were the 52-week high and 52-week low respectively. Overall, CRBP moved -7.11% over the past month.
Corbus Pharmaceuticals Holdings Inc’s market cap currently stands at around $94.34 million, with investors looking forward to this quarter’s earnings report slated for on 2025-May-06.
Turning to the stock’s technical picture we see that short term indicators suggest on average that CRBP is a Hold. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
4 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 4 recommend CRBP as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
CRBP’s current price about -7.38% and -0.67% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 47.66, while 7-day volatility ratio is 7.34% and 6.71% in the 30-day chart. Further, Corbus Pharmaceuticals Holdings Inc (CRBP) has a beta value of 3.19. Analysts have given the company’s stock an average 52-week price target of $60, forecast between a low of $35 and high of $82. Looking at the price targets, the low is -353.96% off current price level while to achieve the yearly target high, price needs to move -963.55%. Nonetheless, investors will most likely welcome a -678.21% jump to $60 which is the analysts’ median price.
If we refocus on Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP), historical trading data shows that trading volumes averaged 0.31 over the past 10 days and 173.75K over the past 3 months. The company’s latest data on shares outstanding shows there are 12.23 million shares.
The 12.59% of Corbus Pharmaceuticals Holdings Inc’s shares are in the hands of company insiders while institutional holders own 82.45% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 1.87 million on 2025-06-13, giving us a short ratio of 14.78. The data shows that as of 2025-06-13 short interest in Corbus Pharmaceuticals Holdings Inc (CRBP) stood at 1903.0 of shares outstanding, with shares short falling to 1.89 million registered in 2025-05-15. Current price change has pushed the stock -84.39% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the CRBP stock continues to rise going into the next quarter.
